Orientia tsutsugamushi Modulates RIPK3 Cellular Levels but Does Not Inhibit Necroptosis
Thomas E Siff1, Paige E Allen1, David L Armistead1
1Department of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.
Abstract:
Scrub typhus is an emerging chigger-borne disease caused by the obligate intracellular bacterium Orientia tsutsugamushi. Necroptosis is a form of programmed cell death (PCD) mediated by RIPK3 (serine/threonine kinase receptor interacting protein 3) and its downstream effector MLKL (mixed-lineage kinase domain-like). While O. tsutsugamushi modulates apoptosis, another form of PCD, its interplay with necroptosis is unknown. Much of Orientia pathobiology is linked to its ankyrin repeat (AR)-containing effectors (Anks). Two of these, Ank1 and Ank6, share similarities with the cowpox AR protein, vIRD (viral inducer of RIPK3 degradation) that prevents necroptosis. Here, we show that Ank1 and Ank6 reduce RIPK3 cellular levels although not as robustly as and mechanistically distinct from vIRD. Orientia infection lowers RIPK3 amounts and does not elicit necroptosis in endothelial cells. In HeLa cells ectopically expressing RIPK3, Orientia fails to inhibit RIPK3 and MLKL phosphorylation as well as cell death. MLKL colocalization with Orientia or Listeria monocytogenes, another intracytoplasmic pathogen, was not observed. Thus, O. tsutsugamushi reduces cellular levels of RIPK3 and does not elicit necroptosis but cannot inhibit this PCD pathway once it is induced. This study is a first step toward understanding how the relationship between Orientia and necroptosis contributes to scrub typhus pathogenesis.
Insights
Scrub typhus bacterium Orientia tsutsugamushi lowers RIPK3 levels, preventing necroptosis. However, it cannot inhibit this programmed cell death pathway once initiated, offering insights into disease mechanisms.
Area of Science:
- Microbiology
- Cell Biology
- Immunology
Background:
- Scrub typhus, caused by Orientia tsutsugamushi, is an emerging infectious disease.
- Necroptosis is a programmed cell death pathway regulated by RIPK3 and MLKL.
- The interaction between O. tsutsugamushi and necroptosis remains unexplored.
Purpose of the Study:
- To investigate the interplay between Orientia tsutsugamushi infection and necroptosis.
- To determine if O. tsutsugamushi effectors Ank1 and Ank6 modulate necroptosis.
- To understand how O. tsutsugamushi influences RIPK3 and MLKL activity.
Main Methods:
- Analysis of RIPK3 levels in O. tsutsugamushi-infected cells.
- Assessment of necroptosis induction in endothelial and HeLa cells.
- Investigation of RIPK3 and MLKL phosphorylation and cell death.
- Microscopy to observe MLKL colocalization.
Main Results:
- O. tsutsugamushi infection reduces cellular RIPK3 levels.
- Ank1 and Ank6 partially decrease RIPK3 levels, distinct from vIRD.
- O. tsutsugamushi does not induce necroptosis in endothelial cells.
- O. tsutsugamushi fails to inhibit RIPK3/MLKL phosphorylation and cell death in induced systems.
- MLKL did not colocalize with O. tsutsugamushi or Listeria monocytogenes.
Conclusions:
- O. tsutsugamushi reduces RIPK3 levels and avoids inducing necroptosis.
- The bacterium cannot inhibit necroptosis once triggered.
- This study provides foundational insights into the role of necroptosis in scrub typhus pathogenesis.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Regulation of the Unfolded Protein Response
The Intrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...


